Advertisement
Research Article| Volume 345, ISSUE 1-2, P202-208, October 15, 2014

Download started.

Ok

Trends of hospitalized acute stroke care in Germany from clinical trials to bedside. Comparison of nation-wide administrative data 2008–2012

      Highlights

      • We analyzed administrative data of a total of 458,753 stroke patients in Germany.
      • The overall rate of intravenous thrombolysis increased from 5.6% to 10.2%.
      • Every 46th stroke patient <80 years was treated interventionally in 2012.
      • Rate of specialized stroke unit care is still lower in women than in men.
      • A “Yentl-syndrome” cannot be excluded in cases of minor stroke symptoms.

      Abstract

      Promising advances in stroke medicine have been reported recently regarding specialized stroke unit (SU) care, expansion of the time window of iv thrombolysis (IVT), mechanical thrombectomy (MT), and decompressive hemicraniectomy (DHC) for malignant brain infarction. It remains unclear to what extent new evidence of therapeutic procedures is transferred to the “real-world” of everyday hospital care.
      We analyzed epidemiologic and procedural therapeutic trends of hospitalized acute stroke patients in Germany by the comparison of administrative hospital data of the years 2008 (n = 219,359) and 2012 (n = 239,394).
      Proportion of specialized SU care rose from 43.4% to 56.9%. Even in age-matched analysis women were less likely to obtain this procedure. Rate of IVT increased from 5.6% to 10.2%. 32% of IVT therapies in 2012 were performed in patients over 80 years. Number of MT increased exponentially from 298 to 3906 procedures. Number of DHC did not increase significantly (2008 = 636; 2011 = 796).
      A strong momentum in transferring scientific insights to the “real-world” stroke care in Germany was documented. Increase of IVT therapy is largely due to the increase of off-label treatment. Almost every 46th patient <80 years was treated by MT in 2012. Despite proven benefits in selected patients, utilization of DHC remained almost stable.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Heuschmann P.U.
        • Busse O.
        • Wagner M.
        • Endres M.
        • Villringer A.
        • Röther J.
        • et al.
        Frequency and care of stroke in Germany.
        Akt Neurol. 2010; 37: 333-340
        • Saver J.L.
        • Jahan R.
        • Levy E.I.
        • Jovin T.G.
        • Baxter B.
        • Nogueira R.G.
        • et al.
        Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial.
        Lancet. 2012; 380: 1241-1249
        • Nogueira R.G.
        • Lutsep H.L.
        • Gupta R.
        • Jovin T.G.
        • Albers G.W.
        • Walker G.A.
        • et al.
        Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial.
        Lancet. 2012; 380: 1231-1240
        • Seenan P.
        • Long M.
        • Langhorne P.
        Stroke units in their natural habitat. Systematic review of observational studies.
        Stroke. 2007; 38: 1886-1892
        • Hacke W.
        • Kaste M.
        • Bluhmki E.
        • Brozman M.
        • Dávalos A.
        • Guidetti D.
        • et al.
        Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke.
        N Engl J Med. 2008; 359: 1317-1329
        • Dávalos A.
        • Pereira V.M.
        • Chapot R.
        • Bonafé A.
        • Andersson T.
        • Gralla J.
        • et al.
        Retrospective multicenter study of Solitaire FR for revascularization in the treatment of acute ischemic stroke.
        Stroke. 2012; 43: 2699-2705
        • Vahedi K.
        • Hofmeijer J.
        • Juettler E.
        • Vicaut E.
        • George B.
        • Algra A.
        • et al.
        Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials.
        Lancet Neurol. 2007; 6: 215-222
        • Eyding J.
        • Kitzrow M.
        • Bartig D.
        • Sorgenfrei H.U.
        • Krogias H.U.
        Reality of acute stroke patient care in the metropolitan Ruhr area: status quo and perspectives of a stroke-specific network.
        Nervenarzt. 2012; 83: 1625-1631
        • Nimptsch U.
        • Mansky T.
        Trends in acute inpatient stroke care in Germany — an observational study using administrative hospital data from 2005–2010.
        Dtsch Arztebl Int. 2012; 109: 885-892
        • Ringelstein E.
        • Busse O.
        • Ritter M.
        Concepts of stroke units in Germany and Europe.
        Nervenheilkunde. 2010; 29: 836-842
        • Walter A.
        • Seidel G.
        • Thie A.
        • Raspe H.
        Semi-intensive stroke unit versus conventional care in acute ischemic stroke or TIA — a prospective study in Germany.
        J Neurol Sci. 2009; 287: 131-137
        • Audebert H.J.
        • Schultes K.
        • Tietz V.
        • Heuschmann P.U.
        • Bogdahn U.
        • Haberl R.L.
        • et al.
        Long-term effects of specialized stroke care with telemedicine support in community hospitals on behalf of the Telemedical Project for Integrative StrokeCare (TEMPiS).
        Stroke. 2009; 40: 902-908
        • Healy B.
        The Yentl syndrome.
        N Engl J Med. 1991; 325: 274-276
        • Wardlaw J.M.
        • Murray V.
        • Berge E.
        • del Zoppo G.
        • Sandercock P.
        • Lindley R.L.
        • et al.
        Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis.
        Lancet. 2012; 379: 2364-2372
        • Karlinski M.
        • Kobayashi A.
        • Mikulik R.
        • Sanak D.
        • Wahlgren N.
        • Czlonkowska A.
        • et al.
        Intravenous alteplase in ischemic stroke patients not fully adhering to the current drug license in Central and Eastern Europe.
        Int J Stroke. 2012; 7: 615-622
        • Sandercock P.
        • Wardlaw J.M.
        • Lindley R.I.
        • Dennis M.
        • Cohen G.
        • Murray G.
        • et al.
        The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
        Lancet. 2012; 379: 2352-2363
        • Mishra N.K.
        • Diener H.C.
        • Lyden P.D.
        • Bluhmki E.
        • Lees K.R.
        Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA).
        Stroke. 2010; 41: 2840-2848
        • Stolz E.
        • Hamann G.F.
        • Kaps M.
        • Misselwitz B.
        Regional differences in acute stroke admission and thrombolysis rates in the German federal state of Hesse.
        Dtsch Arztebl Int. 2011; 108: 607-611
        • Eyding J.
        • Grönheit W.
        • Rother S.
        • Skodda S.
        • Heuser L.
        • Alekseyev A.
        • et al.
        Optimised rate of specific, revascularising therapies in acute stroke — what is the aim? Considerations from the experience of a tertiary centre.
        Fortschr Neurol Psychiatr. 2013; 81: 69-74
        • Rha J.H.
        • Saver J.L.
        The impact of recanalization on ischemic stroke outcome: a meta-analysis.
        Stroke. 2007; 38: 967-973
        • Eyding J.
        • Weimar C.
        • Brassel F.
        • Kitzrow M.
        • Krogias C.
        • Rudel G.
        • et al.
        The “Neurovascular Net Ruhr” concept and implementation of a transregional network to optimize neurovascular treatment of acute stroke patients in the Ruhr District.
        Akt Neurol. 2012; 36: 404-412
        • Broderick J.P.
        • Palesch Y.Y.
        • Demchuk A.M.
        • Yeatts S.D.
        • Khatri P.
        • Hill M.D.
        • et al.
        Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.
        N Engl J Med. 2013; 368: 893-903
        • Ciccone A.
        • Valvassori L.
        • Nichelatti M.
        • Sgoifo A.
        • Ponzio M.
        • Sterzi R.
        • et al.
        Endovascular treatment for acute ischemic stroke.
        N Engl J Med. 2013; 368: 904-913
        • Kidwell C.S.
        • Jahan R.
        • Gornbein J.
        • Alger J.R.
        • Nenov V.
        • Ajani Z.
        • et al.
        A trial of imaging selection and endovascular treatment for ischemic stroke.
        N Engl J Med. 2013; 368: 914-923
        • Molina C.A.
        • Selim M.H.
        Decompressive hemicraniectomy in elderly patients with malignant hemispheric infarction. Open questions remain beyond DESTINY.
        Stroke. 2011; 42: 847-848
        • Bhattachyrya P.
        • Kansara A.
        • Chaturvedi S.
        • Coplin W.
        What drives the increasing utilization of hemicraniectomy in acute ischaemic stroke?.
        J Neurol Neurosurg Psychiatry. 2013; 84: 727-731
        • Haesebaert J.
        • Termoz A.
        • Polazzi S.
        • Mouchoux C.
        • Mechtouff L.
        • Derex L.
        • et al.
        Can hospital discharge databases be used to follow ischemic stroke incidence?.
        Stroke. 2013; 44: 1770-1774
        • Sacco S.
        • Pistoia F.
        • Carolei A.
        Stroke tracked by administrative coding data. Is it fair?.
        Stroke. 2013; 44: 1766-1768